Engineered mesenchymal stem cell-mediated release of the chemokine CCL28 remodels the immune microenvironment to resist graft rejection

被引：0
|
作者：
Li, Yanan [1 ]
Cao, Lu [1 ]
Deng, Yao [1 ]
Wu, Di [1 ]
Gu, Xingshi [1 ]
Ma, Xiaoqian [1 ]
Rong, Pengfei [1 ]
Wang, Wei [1 ]
机构：
[1] Cent South Univ, Cell Transplantat & Gene Therapy Inst, Xiangya Hosp 3, Changsha, Peoples R China
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.077
引用
收藏
页码：483 / 483
页数：1
相关论文
共 18 条
  • [1] Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents
    Waqar, Muhammad Ahsan
    Zaman, Muhammad
    Khan, Rabeel
    Rahman, Muhammad Shafeeq Ur
    Majeed, Imtiaz
    JOURNAL OF DRUG TARGETING, 2024, 32 (06) : 624 - 634
  • [2] Experimental study of glioma stem cell-mediated immune tolerance in tumor microenvironment
    谢涛
    China Medical Abstracts (Internal Medicine), 2018, 35 (01) : 61 - 62
  • [3] p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
    Y Huang
    P Yu
    W Li
    G Ren
    A I Roberts
    W Cao
    X Zhang
    J Su
    X Chen
    Q Chen
    P Shou
    C Xu
    L Du
    L Lin
    N Xie
    L Zhang
    Y Wang
    Y Shi
    Oncogene, 2014, 33 : 3830 - 3838
  • [4] p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
    Huang, Y.
    Yu, P.
    Li, W.
    Ren, G.
    Roberts, A. I.
    Cao, W.
    Zhang, X.
    Su, J.
    Chen, X.
    Chen, Q.
    Shou, P.
    Xu, C.
    Du, L.
    Lin, L.
    Xie, N.
    Zhang, L.
    Wang, Y.
    Shi, Y.
    ONCOGENE, 2014, 33 (29) : 3830 - 3838
  • [5] PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells
    Guo, Xing Rong
    Hu, Qin Yong
    Yuan, Ya Hong
    Tang, Xiang Jun
    Yang, Zhuo Shun
    Zou, Dan Dan
    Bian, Liu Jiao
    Dai, Long Jun
    Li, Dong Sheng
    ONCOLOGY LETTERS, 2016, 11 (04) : 2733 - 2740
  • [6] Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues
    Engelmayr, George C., Jr.
    Sales, Virna L.
    Mayer, John E., Jr.
    Sacks, Michael S.
    BIOMATERIALS, 2006, 27 (36) : 6083 - 6095
  • [7] Mesenchymal Stem Cell-Mediated Immuno-Modulatory and Anti-Inflammatory Mechanisms in Immune and Allergic Disorders
    Gugjoo, Mudasir B.
    Hussain, Shahid
    Amarpal
    Shah, Riaz A.
    Dhama, Kuldeep
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2020, 14 (01) : 3 - 14
  • [8] Role of CTLA-4 and PD-L1 in mesenchymal stem cell-mediated immune modulation
    Turk-Mazlo, A.
    Poliska, S.
    Bene, K.
    Kovacs, R.
    Magi, E.
    Apati, I
    Rajnavolgyi, I
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 155 - 155
  • [9] Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells
    Bae, Sooneon
    Lee, Ho-Joon
    Lee, Jeoung Soo
    Webb, Ken
    BIOMACROMOLECULES, 2015, 16 (09) : 2757 - 2765
  • [10] CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy engineered with next-generation CRISPR technology to resist both the immunosuppressive tumor microenvironment and immune cell-mediated rejection, for patients with relapsed or refractory acute myeloid leukemia
    Garner, Elizabeth
    Kelly, Erin
    Namburi, Sai
    Colgan, Cian
    Fowler, Tristan
    Mutha, Devin
    Aviles, Art
    Stanaway, Morena
    Guo, Raymond
    An, Zili
    Degagne, Emilie
    Kwong, George
    Edwards, Leslie
    Jakes, Emma
    Shaw, Mckay
    Schilling, Benjamin
    Huynh, Jeremy
    Luu, Ricky
    Sidorov, Max
    Mousali, Rhonda
    Otsmaa, Mikk
    Skoble, Justin
    Kanner, Steven
    CANCER RESEARCH, 2023, 83 (07)
12